Inhibition of circ-LAMP1 decreased cell proliferation and invasion of CCA cell lines in vitro, as well as CCA tumor growth in xenograft mouse models, indicating the potentials of circ-LAMP1 as a biomarker and therapeutic target of CCA [98]. The gene discussed is LAMP1; the disease is cholangiocarcinoma.